Clinical Trial Update: A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Japanese Participants With Primary Advanced or Recurrent Endometrial Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating dostarlimab in combination with carboplatin-paclitaxel in Japanese participants with primary advanced or recurrent endometrial cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Dostarlimab (dostarlimab)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING